Related Experiment Video
Updated: Feb 14, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Is global elimination of HCV realistic?
Vincenza Calvaruso1, Salvatore Petta1, Antonio Craxì1
1Sezione di Gastroenterologia & Epatologia, DIBIMIS, Università di Palermo, Palermo, Italy.
Insights
New antiviral drugs offer a path to eliminate hepatitis C virus (HCV) infection. Achieving the World Health Organization
Area of Science:
- Hepatology and Infectious Diseases
- Public Health and Epidemiology
Background:
- Hepatitis C virus (HCV) infection remains a significant global health concern.
- New direct-acting antiviral (DAA) drugs have revolutionized HCV treatment, offering high cure rates.
- The World Health Organization (WHO) has set ambitious targets for HCV elimination by 2030.
Purpose of the Study:
- To review the current epidemiology of HCV infection.
- To discuss strategies for increasing patient awareness and overcoming treatment barriers.
- To examine the impact of HCV clearance on disease outcomes.
Main Methods:
- Literature review of epidemiological data on HCV.
- Analysis of current treatment guidelines and access to care.
- Discussion of public health interventions for HCV control.
Main Results:
- DAA therapy is effective even in patients with advanced liver disease (decompensated cirrhosis).
- Significant reductions in HCV incidence and mortality are achievable with comprehensive strategies.
- Effective HCV elimination requires integrated approaches including screening, linkage to care, and treatment.
Conclusions:
- HCV elimination is a feasible goal with current antiviral therapies.
- Public health initiatives focusing on awareness, screening, and access to treatment are crucial.
- Successful HCV clearance contributes to reducing HCV-related morbidity and mortality.
Abstract:
The elimination of hepatitis C virus (HCV) has been made possible through the availability of new antiviral drugs which may now be administered to all patients with HCV infection, even those with decompensated cirrhosis. The goal of the World Health Organization (WHO) is to reduce the incidence of chronic hepatitis infection from the current 6-10 million to 0.9 million cases of chronic infections by 2030, and annual deaths from 1.4 million to fewer than 0.5 million. Achieving these targets will require full implementation of epidemiological knowledge of HCV infection, screening and testing practices and strategies to link HCV patients to care. This review will focus on the current state of knowledge in the epidemiology of HCV and what can be done to increase patient awareness and reduce the barriers to treatment. Furthermore, we will discuss the role of HCV clearance on the control of HCV-related outcomes.
More Related Videos
09:04Recording Ultra-Realistic Full-Color Analog Holograms for Use in a Moving Hologram Display
Published on: January 14, 2020
07:31Author Spotlight: Advancing Cell Membrane Biophysics - Exploring Interactions and Challenges Through Experimental and Computational Approaches
Published on: September 1, 2023
Related Concept Videos
Global Climate Change
Elimination Kinetics: First-Order and Zero-Order
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Elimination Reactions
Radical Formation: Elimination
Gaussian Elimination: Problem Solving
Kinetics of Drug Elimination
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...